TGFBR1 haplotypes and risk of non-small-cell lung cancer.
Transforming growth factor beta (TGF-beta) receptors are centrally involved in TGF-beta-mediated cell growth and differentiation and are frequently inactivated in non-small-cell lung cancer (NSCLC). Constitutively decreased type I TGF-beta receptor (TGFBR1) expression is emerging as a novel tumor-predisposing phenotype. The association of TGFBR1 haplotypes with risk for NSCLC has not yet been studied. We tested the hypothesis that single-nucleotide polymorphisms (SNP) and/or TGFBR1 haplotypes are associated with risk of NSCLC. We genotyped six TGFBR1 haplotype-tagging SNPs (htSNP) by PCR-RFLP assays and one htSNP by PCR-single-strand conformation polymorphism assay in two case-control studies. Case-control study 1 included 102 NSCLC patients and 104 healthy controls from Suzhou. Case-control study 2 included 131 patients with NSCLC and 133 healthy controls from Wuxi. Individuals included in both case-control studies were Han Chinese. Haplotypes were reconstructed according to the genotyping data and linkage disequilibrium status of these seven htSNPs. None of the htSNP was associated with NSCLC risk in either study. However, a four-marker CTGC haplotype was significantly more common among controls than among cases in both studies (P = 0.014 and P = 0.010, respectively), indicating that this haplotype is associated with decreased NSCLC risk {adjusted odds ratio [OR], 0.09 [95% confidence interval (95% CI), 0.01-0.61] and 0.11 [95% CI, 0.02-0.59], respectively}. Combined analysis of both studies shows a strong association of this four-marker haplotype with decreased NSCLC risk (adjusted OR, 0.11; 95% CI, 0.03-0.39). This is the first evidence of an association between a TGFBR1 haplotype and risk for NSCLC.
Lei
Zhe
Z
Laboratory of Medical Genetics, School of Basic Medicine and Biological Sciences, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, PR China.
Liu
Reng-Yun
RY
Zhao
Jun
J
Liu
Zeyi
Z
Jiang
Xiefang
X
You
Weiming
W
Chen
Xiao-Feng
XF
Liu
Xia
X
Zhang
Kui
K
Pasche
Boris
B
Zhang
Hong-Tao
HT
D000367:Age Factors; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D007438:Introns; D015810:Linkage Disequilibrium; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D000077293:Receptor, Transforming Growth Factor-beta Type I; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics*; D012737:Sex Factors
D018125:Receptors, Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D000077293:Receptor, Transforming Growth Factor-beta Type I; C000625841:TGFBR1 protein, human
Atherosclerosis. 2009 Jan;202(1):205-10
18550062
J Clin Oncol. 2004 Feb 15;22(4):756-8
14966109
Lung Cancer. 2002 Nov;38(2):143-7
12399125
Cancer Res. 2008 Mar 1;68(5):1319-28
18316594
Cancer Res. 2001 Jun 15;61(12):4679-82
11406536
Oncogene. 2002 Oct 7;21(45):6870-6
12362269
Eur J Hum Genet. 2001 Apr;9(4):291-300
11313774
Clin Cancer Res. 2006 Jan 15;12(2):392-7
16428477
Mol Cell Biol. 1996 Jul;16(7):3480-9
8668164
Br J Cancer. 2007 Oct 22;97(8):1175-9
17848956
Br J Cancer. 2004 Jun 1;90(11):2157-66
15150609
Cancer Res. 1999 Nov 15;59(22):5678-82
10582683
JAMA. 2005 Oct 5;294(13):1634-46
16204663
J Thorac Oncol. 2007 Jul;2(7):657-9
17607123
Cancer Res. 2009 Jan 15;69(2):678-86
19147584
Lung Cancer. 2008 Feb;59(2):232-9
17905467
Int J Cancer. 2004 Nov 10;112(3):420-5
15382067
Nat Med. 1998 Jul;4(7):802-7
9662371
Cell. 2003 Jun 13;113(6):685-700
12809600
Am J Hum Genet. 2004 Jan;74(1):106-20
14681826
Nat Genet. 2008 Dec;40(12):1404-6
18978790
Cytokine. 2003 Dec 7;24(5):182-9
14596814
Science. 2008 Sep 5;321(5894):1361-5
18703712
Clin Cancer Res. 1998 Jul;4(7):1625-30
9676836
Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):211-4
11867510
Cell Res. 2005 Feb;15(2):97-8
15740637
Lung Cancer. 2003 Jun;40(3):281-7
12781426
Pancreas. 1999 Nov;19(4):370-6
10547197
Int J Cancer. 1999 Jul 2;82(1):43-51
10360819
Lung Cancer. 2005 Sep;49(3):419-20
15955593
Cancer Res. 2001 Sep 15;61(18):6665-8
11559531
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3081-9
18990748
Cancer Res. 2000 Aug 15;60(16):4507-12
10969799
Int J Cancer. 2001 Sep 1;93(5):653-61
11477574
Clin Cancer Res. 1999 Sep;5(9):2520-5
10499628